Results of andante, a randomized clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are anti-tnf inadequate responders

Category Primary study
JournalGastroenterology
Year 2016
This article has no abstract
Epistemonikos ID: 36333c3f006e142145effdb868810303386da4db
First added on: Feb 07, 2025